Thursday 16 October, 2025
Objectives: The primary aim of this work was to characterize the exposure response (overall daily pain score, DPS) relationship across…
Read moreObjectives: The primary aim of this work was to characterize the exposure response (overall daily pain score, DPS) relationship across…
Read moreObjectives: Certolizumab pegol (CZP) is a pegylated Fab´ fragment of a humanized anti-TNF antibody. The aim of the analysis was…
Read morePharmacokinetic and pharmacodynamic (PKPD) modeling, together with clinical trial simulation is recognized as one of the emerging technologies that can…
Read more